CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-31 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −1,327 | $32.46 | $43K | 93,146 |
| 2025-01-30 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award | +3,607 | 94,473 | ||
| 2025-01-16 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −6,752 | $32.90 | $222K | 90,866 |
| 2025-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion | +18,011 | 97,618 | ||
| 2025-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Performance Restricted Stock Units | +22,000 | 63,482 | ||
| 2025-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +33,000 | 56,500 | ||
| 2025-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion · Restricted Stock Unit | −18,011 | 38,489 | ||
| 2025-01-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2024-08-30 | BENNETT C FRANK EVP, Chief Scientific Officer | Other acquisition | +177 | $38.64 | $7K | 79,607 |
| 2024-02-29 | BENNETT C FRANK Officer Level 14 | Other acquisition | +383 | $34.43 | $13K | 79,462 |
| 2024-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −1,885 | $49.52 | $93K | 79,047 |
| 2024-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −1,853 | $49.52 | $92K | 79,079 |
| 2024-02-01 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award | +3,609 | 80,932 | ||
| 2024-01-17 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −6,745 | $50.42 | $340K | 77,323 |
| 2024-01-16 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion | +18,314 | 84,068 | ||
| 2024-01-16 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion · Restricted Stock Unit | −18,314 | 23,500 | ||
| 2024-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Performance Restricted Stock Units | +17,000 | 41,482 | ||
| 2024-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +20,400 | 41,814 | ||
| 2024-01-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +27,200 | 27,200 | ||
| 2023-12-21 | BENNETT C FRANK EVP, Chief Scientific Officer | Exercise or conversion 10b5-1 | +16,113 | $47.34 | $763K | 81,867 |
Page 3 of 5 · 82 trades